Evaluate Use of Mangosteen Juice Added to Usual Care in Reducing Risk of Recurrent Atrial Fibrillation

NCT00951301 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

143

Enrollment

OTHER

Sponsor class

Stopped Significantly lower accrual rate than anticipated, time constraints.

Conditions

Atrial Fibrillation

Interventions

DRUG: mangosteen juice
DRUG: placebo juice

Sponsor

Mayo Clinic